However, the lack of correlation of ApoC1 serum values to tumor volume on MRI and to protein expression in histological slides, as well as the missing relationship of ApoC1 levels to survival time do not favor the use of ApoC1 as serum biomarker or prognostic marker for glioblastoma. This evidence concerns the gene APOC1 and glioblastoma.